ASTRO: HRQOL Superior With SBRT for Intermediate-Risk Localized Prostate Cancer
Favorable bowel HRQOL seen with stereotactic body radiation therapy compared with intensity-modulated radiation therapy; no difference seen in disease-free survival
2015 to 2024 Saw Increase in Testing for Lipoprotein(a)
Increase reported in annual number of tested patients and percentage of total patient population tested, reaching 0.24 percent in 2024
Globally, 18.5 Million Incident Cancer Cases and 10.4 Million Deaths Reported in 2023
30.5 and 18.6 million cases and deaths from cancer globally anticipated in 2050 based on reference forecasts
Artificial Intelligence Tool Can Differentiate Glioblastomas From CNS Lymphoma
Results were validated in five independent cohorts, with AUROCs ranging from 0.924 to 0.996
Walmart Pledges to Ditch Several Artificial Colors and Additives by 2027
Experts praise the commitment as a significant response to consumer desire for cleaner ingredient lists
Skipping First Mammogram Screening Increases Long-Term Breast Cancer Mortality Risk
Higher mortality likely reflects delayed detection, not higher incidence
Cancer Survival Lower in Rural Areas
Survival rates also are lower for Black versus White people across various cancer types and categories of urbanicity
Elderly Patients Benefit From Screening Mammography
Women 80 years and older with screening more likely to present with earlier-stage disease and have better survival versus unscreened women
Adherence to ACS Guideline Linked to Lower Mortality in Nonmetastatic Prostate Cancer
Lower mortality risk seen for those who improved guideline concordance after diagnosis or maintained high concordance
FDA Approves Inluriyo for Advanced Breast Cancer
Approval is for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
